Cardinal Health (NYSE:CAH) Stock Acquired Rep. Robert Bresnahan, Jr.

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Cardinal Health, Inc. (NYSE:CAH). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cardinal Health stock on April 8th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 4/17/2025.
• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 4/16/2025.
• Sold $1,001 – $15,000 in shares of Western Digital (NASDAQ:WDC) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Western Digital (NASDAQ:WDC) on 4/10/2025.
• Sold $1,001 – $15,000 in shares of DexCom (NASDAQ:DXCM) on 4/8/2025.
• Sold $1,001 – $15,000 in shares of Invesco (NYSE:IVZ) on 4/8/2025.
• Sold $1,001 – $15,000 in shares of Generac (NYSE:GNRC) on 4/8/2025.
• Sold $15,001 – $50,000 in shares of Occidental Petroleum (NYSE:OXY) on 4/8/2025.
• Sold $15,001 – $50,000 in shares of Pfizer (NYSE:PFE) on 4/8/2025.
• Sold $1,001 – $15,000 in shares of QUALCOMM (NASDAQ:QCOM) on 4/8/2025.

Cardinal Health Stock Up 0.7%

Cardinal Health stock opened at $148.36 on Monday. The company’s fifty day simple moving average is $134.65 and its 200-day simple moving average is $126.50. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $154.07. The stock has a market cap of $35.41 billion, a P/E ratio of 27.68, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to analysts’ expectations of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Cardinal Health’s revenue for the quarter was up .0% on a year-over-year basis. During the same period in the prior year, the company posted $2.08 earnings per share. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.5107 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a dividend yield of 1.38%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health’s payout ratio is currently 31.83%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CAH. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Monday, May 5th. JPMorgan Chase & Co. boosted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Bank of America boosted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Morgan Stanley upped their price objective on shares of Cardinal Health from $142.00 to $166.00 and gave the company an “overweight” rating in a research report on Monday, May 5th. Finally, Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $146.43.

Institutional Trading of Cardinal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Barclays PLC boosted its position in shares of Cardinal Health by 8.2% during the third quarter. Barclays PLC now owns 707,404 shares of the company’s stock worth $78,183,000 after purchasing an additional 53,851 shares in the last quarter. Franklin Resources Inc. grew its stake in Cardinal Health by 6.6% in the 3rd quarter. Franklin Resources Inc. now owns 151,185 shares of the company’s stock valued at $16,918,000 after buying an additional 9,385 shares during the last quarter. Nordea Investment Management AB grew its position in shares of Cardinal Health by 6.0% during the 4th quarter. Nordea Investment Management AB now owns 22,372 shares of the company’s stock worth $2,659,000 after purchasing an additional 1,259 shares in the last quarter. Graypoint LLC grew its position in shares of Cardinal Health by 76.8% during the 4th quarter. Graypoint LLC now owns 4,208 shares of the company’s stock worth $498,000 after purchasing an additional 1,828 shares in the last quarter. Finally, Czech National Bank lifted its holdings in shares of Cardinal Health by 5.6% during the 4th quarter. Czech National Bank now owns 52,473 shares of the company’s stock worth $6,206,000 after acquiring an additional 2,800 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.